Britannia Life Sciences Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Market Capitalization	12	11	15	31	-	-
Market Cap Growth	6.67%	-26.32%	-49.89%	-	-	-
Enterprise Value	23	21	25	38	-	-
Last Close Price	0.07	0.07	0.10	0.19	-	-
PE Ratio	-	-	3.03	-	-	-
PS Ratio	1.69	1.50	2.41	4.21	-	-
PB Ratio	10.30	1.70	1.39	5.61	-	-
P/FCF Ratio	11.20	5.80	7.89	11.34	-	-
P/OCF Ratio	11.65	5.43	7.68	10.99	-	-
EV/Sales Ratio	3.19	2.76	3.90	5.26	-	-
EV/EBITDA Ratio	27.26	14.82	22.64	21.88	-	-
EV/EBIT Ratio	27.10	16.24	25.15	23.75	-	-
EV/FCF Ratio	21.12	10.68	12.80	14.15	-	-
Debt / Equity Ratio	1.22	1.09	0.76	0.95	3.96	-
Debt / EBITDA Ratio	7.14	4.80	7.31	2.88	32.63	-
Debt / FCF Ratio	6.54	3.72	4.31	1.92	-	-
Asset Turnover	0.32	0.33	0.29	0.34	0.13	-
Quick Ratio	0.18	0.24	0.91	0.41	0.25	1.03
Current Ratio	0.20	0.26	0.92	0.42	0.25	1.03
Return on Equity (ROE)	-83.66%	-49.61%	70.57%	-343.40%	10.72%	-
Return on Assets (ROA)	2.47%	3.51%	2.78%	4.75%	1.67%	-
Return on Capital (ROIC)	3.46%	4.81%	4.12%	8.46%	2.73%	-
Return on Capital Employed (ROCE)	8.50%	10.90%	5.20%	12.70%	2.60%	-
Earnings Yield	-65.57%	-41.98%	32.98%	-50.26%	-	-
FCF Yield	8.93%	17.23%	12.67%	8.82%	-	-
Buyback Yield / Dilution	0.05%	-0.07%	-48.07%	-41.06%	-1138.06%	-

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.